Collectively, resveratrol may be a potential EMT-reversal agent for the treatment of metastatic CRC by restraining the AKT/GSK-3β/Snail signal pathway (Yuan et al., 2019b). This evidence concerns the gene AKT1 and colorectal carcinoma.